# FDA Inspection 1289866 - Primus Pharmaceuticals, Inc. - July 23, 2026

Source: https://www.keypedia.com/records/fda_inspections/primus-pharmaceuticals-inc/39dbcc97-e845-44b0-af6c-26a126e3a1e6
Source feed: FDA_Inspections

> FDA Inspection 1289866 for Primus Pharmaceuticals, Inc. on July 23, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1289866
- Company Name: Primus Pharmaceuticals, Inc.
- Inspection Date: 2026-07-23
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Office Name: Denver District Office

Company: https://www.keypedia.com/companies/primus-pharmaceuticals-inc/8008dd6e-1b85-49af-a685-c61db43a6c98

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face